Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis

BACKGROUND: The impact of different anti-virus regimens on prognosis of Chronic hepatitis B (CHB) related cirrhosis remains to be explored. We aim to investigate whether CHB-related HCC patients receiving nucleoside analogue regimen or not have a different prognosis. METHODS: Two hundred forty-two C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Liu, Qingli, Yuan, Mei, Wang, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114711/
https://www.ncbi.nlm.nih.gov/pubmed/30181772
http://dx.doi.org/10.1186/s13027-018-0203-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114711/
https://www.ncbi.nlm.nih.gov/pubmed/30181772
http://dx.doi.org/10.1186/s13027-018-0203-8

Ejemplares similares